Drug recall · December 23, 2020
Vumerity recall
Why: Failed dissolution specifications: out-of-specification test results observed during the buffer stage dissolution testing.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Vumerity (diroximel fumarate) delayed-release capsule, 231 mg, packaged in a) 106-count bottle, b)120-count bottle, Rx only, Manufactured for: Biogen Inc., Cambridge, MA 02142, NDC 64406-020-01
- Lots / codes
Lot #: a) 101801, Exp 5/31/2021; 102826, Exp 6/21/2021; b) 101799, Exp 5/31/2021; 102362, Exp 6/21/2021
- Quantity
- 5,307 bottles
- Company
- Biogen MA Inc., Research Triangle Park, NC
- Distribution
- USA Nationwide
- Initiated
- December 9, 2020 · Voluntary: Firm initiated
- Classified
- December 14, 2020
- Reported
- December 23, 2020
- Ended
- September 17, 2021
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.